English | Español
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
Patient Daily | Mar 16, 2026

Xenon to seek approval of first-in-class epilepsy drug after exceeding Phase 3 expectations
Patient Daily | Mar 16, 2026

Terasaki Institute and Keck Graduate Institute announce biomedical research partnership
Patient Daily | Mar 16, 2026

Researchers use long-read genome sequencing to identify new autism-linked genetic variants
Patient Daily | Mar 16, 2026

Study finds sleep and diet are major factors in immune system variation
Patient Daily | Mar 16, 2026

Study links greater tattoo coverage to higher levels of certain personality traits
Patient Daily | Mar 16, 2026

Enzyme linked to maintenance of retinal progenitor cells during eye development
Patient Daily | Mar 16, 2026

Researchers validate Mpox antibody test during outbreak in Rwanda

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'